These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32889078)

  • 21. Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.
    Su S; Zhu Y; Ye S; Qi Q; Xia S; Ma Z; Yu F; Wang Q; Zhang R; Jiang S; Lu L
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Small-molecule HIV-1 entry inhibitors targeting gp120 and gp41: a patent review (2010-2015).
    Li W; Lu L; Li W; Jiang S
    Expert Opin Ther Pat; 2017 Jun; 27(6):707-719. PubMed ID: 28076686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-1 gp41 Residues Modulate CD4-Induced Conformational Changes in the Envelope Glycoprotein and Evolution of a Relaxed Conformation of gp120.
    Keller PW; Morrison O; Vassell R; Weiss CD
    J Virol; 2018 Aug; 92(16):. PubMed ID: 29875245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of peptide fragment 828-848 of the envelope glycoprotein of human immunodeficiency virus type I with lipid bilayers.
    Gawrisch K; Han KH; Yang JS; Bergelson LD; Ferretti JA
    Biochemistry; 1993 Mar; 32(12):3112-8. PubMed ID: 8457572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of HIV-1 fusion inhibitors targeting gp41.
    Lu K; Asyifah MR; Shao F; Zhang D
    Curr Med Chem; 2014 Jun; 21(17):1976-96. PubMed ID: 24350848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural and Thermodynamic Analysis of HIV-1 Fusion Inhibition Using Small gp41 Mimetic Proteins.
    Jurado S; Cano-Muñoz M; Morel B; Standoli S; Santarossa E; Moog C; Schmidt S; Laumond G; Cámara-Artigas A; Conejero-Lara F
    J Mol Biol; 2019 Aug; 431(17):3091-3106. PubMed ID: 31255705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Helical interactions in the HIV-1 gp41 core reveal structural basis for the inhibitory activity of gp41 peptides.
    Shu W; Liu J; Ji H; Radigen L; Jiang S; Lu M
    Biochemistry; 2000 Feb; 39(7):1634-42. PubMed ID: 10677212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ADS-J1 inhibits human immunodeficiency virus type 1 entry by interacting with the gp41 pocket region and blocking fusion-active gp41 core formation.
    Wang H; Qi Z; Guo A; Mao Q; Lu H; An X; Xia C; Li X; Debnath AK; Wu S; Liu S; Jiang S
    Antimicrob Agents Chemother; 2009 Dec; 53(12):4987-98. PubMed ID: 19786602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure and interaction with membrane model systems of a peptide derived from the major epitope region of HIV protein gp41: implications on viral fusion mechanism.
    Contreras LM; Aranda FJ; Gavilanes F; González-Ros JM; Villalaín J
    Biochemistry; 2001 Mar; 40(10):3196-207. PubMed ID: 11258936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Membrane-anchored inhibitory peptides capture human immunodeficiency virus type 1 gp41 conformations that engage the target membrane prior to fusion.
    Melikyan GB; Egelhofer M; von Laer D
    J Virol; 2006 Apr; 80(7):3249-58. PubMed ID: 16537592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Covalent fusion inhibitors targeting HIV-1 gp41 deep pocket.
    Bai Y; Xue H; Wang K; Cai L; Qiu J; Bi S; Lai L; Cheng M; Liu S; Liu K
    Amino Acids; 2013 Feb; 44(2):701-13. PubMed ID: 22961335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure and dynamics of micelle-associated human immunodeficiency virus gp41 fusion domain.
    Jaroniec CP; Kaufman JD; Stahl SJ; Viard M; Blumenthal R; Wingfield PT; Bax A
    Biochemistry; 2005 Dec; 44(49):16167-80. PubMed ID: 16331977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thermodynamic dissection of the interface between HIV-1 gp41 heptad repeats reveals cooperative interactions and allosteric effects.
    Jurado S; Cano-Muñoz M; Polo-Megías D; Conejero-Lara F; Morel B
    Arch Biochem Biophys; 2020 Jul; 688():108401. PubMed ID: 32376316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thermodynamics of peptide inhibitor binding to HIV-1 gp41.
    Cole JL; Garsky VM
    Biochemistry; 2001 May; 40(19):5633-41. PubMed ID: 11341828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Membrane-induced conformational change during the activation of HIV-1 gp41.
    Kliger Y; Peisajovich SG; Blumenthal R; Shai Y
    J Mol Biol; 2000 Aug; 301(4):905-14. PubMed ID: 10966795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fatty acids can substitute the HIV fusion peptide in lipid merging and fusion: an analogy between viral and palmitoylated eukaryotic fusion proteins.
    Lev N; Shai Y
    J Mol Biol; 2007 Nov; 374(1):220-30. PubMed ID: 17919659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactions of HIV-1 inhibitory peptide T20 with the gp41 N-HR coiled coil.
    Champagne K; Shishido A; Root MJ
    J Biol Chem; 2009 Feb; 284(6):3619-27. PubMed ID: 19073602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutations of Gln64 in the HIV-1 gp41 N-terminal heptad repeat render viruses resistant to peptide HIV fusion inhibitors targeting the gp41 pocket.
    Yu X; Lu L; Cai L; Tong P; Tan S; Zou P; Meng F; Chen YH; Jiang S
    J Virol; 2012 Jan; 86(1):589-93. PubMed ID: 22013063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-1 envelope protein gp41: an NMR study of dodecyl phosphocholine embedded gp41 reveals a dynamic prefusion intermediate conformation.
    Lakomek NA; Kaufman JD; Stahl SJ; Wingfield PT
    Structure; 2014 Sep; 22(9):1311-1321. PubMed ID: 25132083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adsorption and folding dynamics of MPER of HIV-1 gp41 in the presence of DPC micelle.
    Hartono YD; Mun YY; Zhang D
    Proteins; 2013 Jun; 81(6):933-44. PubMed ID: 23345046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.